Testing a digital, comprehensive, standardised assessment approach to improve the management of people with cancer
| ISRCTN | ISRCTN15235259 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN15235259 |
| Sponsor | Oslo University Hospital |
| Funders | HORIZON EUROPE Health, Innovate UK, Swiss State Secretariat for Education, Research and Innovation (SERI) |
- Submission date
- 18/02/2026
- Registration date
- 18/02/2026
- Last edited
- 18/02/2026
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Cancer
Plain English summary of protocol
Background and study aims
In the MyPath project, we will develop and implement a digital solution for mapping and monitoring symptoms and complaints in cancer patients as part of their cancer treatment. MyPath is a patient-centred digital solution where patients' own assessments of symptoms, complaints and needs are central to decisions about treatment and follow-up during cancer treatment. We believe this will improve symptom mapping and the individual follow-up of patients. The goal is for it to become part of the usual cancer treatment at hospitals in Europe.
The aim of this study is to investigate how well MyPath was put into action as part of cancer patient follow-up at each site and overall.
Who can participate?
The study will collect information from a number of different stakeholders involved in the use of MyPath for the follow-up of patients with cancer: patients aged over 18 years, caregivers, healthcare practitioners, managers at the hospital, and IT staff at the hospital who were involved with the installation of MyPath.
What does the study involve?
Patients will use the MyPath solution as part of their regular follow-up. They will record their symptoms on their mobile phone, PC or tablet before hospital visits. Researchers will collect data from MyPath, including symptom reports (such as pain, energy levels, and concerns) by the patients. In addition, researchers will collect technical usage data from MyPath, such as how much time users spend using MyPath, which functions they click on, and technical errors that occur. Patients will be asked to complete some additional forms that map health-related quality of life and use of healthcare services. They will be asked to complete the forms at regular intervals (for example monthly) during the project. Relevant information will be extracted from the patients’ medical record to evaluate how the solution is used in follow-up, and how healthcare personnel document the use of MyPath. Stakeholders will be invited to individual interviews about their experiences with MyPath. These will last approximately one to one and a half hours. The interviews will be audio recorded. The recordings will be transcribed, and the content analysed according to scientifically recognised methods.
What are the possible benefits and risks of participating?
Participants will not receive any special benefits from participating, but the results and feedback from everyone who participates will provide information that may later be able to help people with cancer. Feedback from the stakeholders will improve MyPath in terms of content, the way questions are asked, the experience of filling out such questions on a tablet or PC, and whether the solution works as expected. Participation will not result in any different treatment or follow-up of patients with cancer than what they would otherwise receive.
Some may find being asked to fill out questionnaires or to participate in conversations or interviews time-consuming and tiring.
Where is the study run from?
Oslo University Hospital (Norway) and University of Edinburgh (UK)
When is the study starting and how long is it expected to run for?
December 2025 to August 2027
Who is funding the study?
1. European Union (grant no. 101057514)
2. Innovate UK
3. Swiss State Secretariat for Education, Research and Innovation (SERI)
Who is the main contact?
Prof. Stein Kaasa, stein.kaasa@medisin.uio.no
Contact information
Public
Oslo University Hospital
Radiumhospitalet
Comprehensive Cancer Centre
Ullernchaussen 70
Oslo
0379
Norway
| Phone | +47 22 93 40 16 |
|---|---|
| likote@ous-hf.no |
Principal investigator
Oslo University Hospital
Radiumhospitalet
Comprehensive Cancer Centre
Ullernchaussen 70
Oslo
0379
Norway
| Phone | +47 918 97 001 |
|---|---|
| stein.kaasa@medisin.uio.no |
Scientific
Cancer Research UK Edinburgh Centre
Institute of Genetics & Cancer
The University of Edinburgh
Western General Hospital
Crewe Road South
Edinburgh
EH4 2XR
United Kingdom
| Phone | +44 (0)131 651 8611 |
|---|---|
| Marie.Fallon@ed.ac.uk |
Study information
| Primary study design | Interventional | |
|---|---|---|
| Allocation | N/A: single arm study | |
| Masking | Open (masking not used) | |
| Control | Uncontrolled | |
| Assignment | Single | |
| Purpose | Implementation science | |
| Scientific title | MyPath – Developing and implementing innovative patient-centred care pathways for cancer patients: formative evaluation | |
| Study acronym | MyPath | |
| Study objectives | The primary objective is to implement the MyPath digital solution at OUS and to perform an iterative, mixed-methods, formative evaluation to enhance adoption of the MyPath solution. | |
| Ethics approval(s) |
Approved 08/12/2025, Data Protection Manager at Oslo University Hospital (Postboks 4950, Nydalen, Oslo, 0424, Norway; +47 (0)22 93 40 00; personvern@ous-hf.no), ref: 25/26142 | |
| Health condition(s) or problem(s) studied | Cancer | |
| Intervention | Implementation of the MyPath digital solution for systematic symptom mapping in cancer patients. Patients will use the MyPath solution as part of their regular follow-up. They will record their symptoms on their mobile phone, PC or tablet before hospital visits. Researchers will collect data from MyPath, including symptom reports (such as pain, energy levels, and concerns) by the patients. In addition, researchers will collect technical usage data from MyPath, such as how much time users spend using MyPath, which functions they click on, and technical errors that occur. Patients will be asked to complete some additional forms that map health-related quality of life and use of healthcare services. They will be asked to complete the forms at regular intervals (for example monthly) during the project. Relevant information will be extracted from the patients’ medical record to evaluate how the solution is used in follow-up, and how healthcare personnel document the use of MyPath. Stakeholders will be invited to individual interviews about their experiences with MyPath. These will last approximately one to one and a half hours. The interviews will be audio recorded. The recordings will be transcribed, and the content analysed according to scientifically recognised methods. | |
| Intervention type | Other | |
| Primary outcome measure(s) |
| |
| Key secondary outcome measure(s) | ||
| Completion date | 31/08/2027 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 18 Years |
| Upper age limit | 110 Years |
| Sex | All |
| Target sample size at registration | 500 |
| Key inclusion criteria | 1. Aged ≥18 years 2. Able to understand and speak the local language 3. Diagnosed with cancer 4. Able to provide informed consent |
| Key exclusion criteria | Potential participants will not be eligible if they have cognitive and or communication difficulties that would make a semi-structured interview/focus group discussion not possible |
| Date of first enrolment | 08/12/2025 |
| Date of final enrolment | 31/03/2027 |
Locations
Countries of recruitment
- United Kingdom
- England
- Scotland
- Belgium
- Denmark
- Italy
- Netherlands
- Norway
- Romania
- Spain
Study participating centres
South Bridge
Edinburgh
EH8 9YL
Scotland
Leeds
LS2 9JT
England
Norway
Denmark
Netherlands
Italy
Spain
Romania
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Available on request |
| IPD sharing plan | With support from the EU commission, the MyPath partners have a shared responsibility for facilitating data sharing in line with the FAIR principles. Based on these principles, a data management plan (DMP) introduces a set of codes on how the partners within the project can contribute to more research collaboration for the good of patients and for society in general by facilitating data sharing in a sound, legal and ethical way. The FAIR principles ensuring practical Findability, Accessibility, Interoperability and Reusability will be followed for all data that are shared between the partners in the course of the MyPath sub-projects. In accordance to the DMP, each MyPath partner will have full legal control over its own data, and no data will be shared or could be accessed by a third party without approval from the responsible partner(s). |
Editorial Notes
18/02/2026: Study's existence confirmed by the European Commission.
